ulcerative colitis therapy (Kintai Therapeutics)

N/A

Report date: 2025/01/26 16:42:23
NME

Base Information

Drug Nameulcerative colitis therapy (Kintai Therapeutics)
Drug Alias Nameprecision-based compound (Kintai)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKintai Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesKintai Therapeutics
Inactive CompaniesN/A
Active IndicationsColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A